AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea flag South Korea · Delayed Price · Currency is KRW
21,250
-5,050 (-19.20%)
At close: Aug 20, 2026

AprilBio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-10,121-9,72820,005-14,130-8,959-52,713
Depreciation & Amortization
672.5689.55706.33674.42593.44487.25
Loss (Gain) From Sale of Assets
--025.870.01-
Loss (Gain) From Sale of Investments
658.95658.95----
Stock-Based Compensation
822.31,1362,127959.84378.87523.33
Other Operating Activities
2,9174,054-637.923,604-1,07357,119
Change in Accounts Receivable
2,172---4,292-4,276
Change in Income Taxes
-225.76-181.1594.9-264.71-159.89-15.57
Change in Other Net Operating Assets
-961.9628.29-335.54-928.88-1,7762,127
Operating Cash Flow
-4,066-3,34221,960-10,059-6,7043,252
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-228.35-287.84-445.29-511.97-89.59-705.82
Sale (Purchase) of Intangibles
-218-----
Investment in Securities
5,6575,893-22,345-6,500-31,500-23,000
Other Investing Activities
27.110.11-6.72-41.77-52.13-93.69
Investing Cash Flow
5,2385,605-22,797-7,054-31,642-23,800

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---14,848--
Long-Term Debt Repaid
--362.24-329.98-291.45-248.24-161.81
Net Debt Issued (Repaid)
-358.91-362.24-329.9814,556-248.24-161.81
Issuance of Common Stock
2,7911,8481,0981,75520,57724,955
Other Financing Activities
-10.34-10.34-3,281-0-0-0
Financing Cash Flow
2,4211,475-2,51316,31220,32834,793

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
92.13-12.07110.51103.16924.37-
Miscellaneous Cash Flow Adjustments
--0--0-
Net Cash Flow
3,6863,726-3,240-697.32-17,09314,245

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-4,294-3,63021,514-10,571-6,7942,546
Free Cash Flow Growth
------
Free Cash Flow Margin
-591.99%-167.14%78.19%--3396.76%10.88%
Free Cash Flow Per Share
-188.49-160.22981.88-495.25-347.29305.34
Levered Free Cash Flow
-8,403-8,3892,4924,066-4,137-18,335
Unlevered Free Cash Flow
-8,129-8,0023,3804,648-4,119-17,014

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
984.28-152.86-240.64-1,1942,356-2,164